{"created":"2023-06-19T07:26:14.306014+00:00","id":14596,"links":{},"metadata":{"_buckets":{"deposit":"d2e78770-6b98-44f7-b39e-ac96d8deb61a"},"_deposit":{"created_by":146,"id":"14596","owners":[146],"pid":{"revision_id":0,"type":"depid","value":"14596"},"status":"published"},"_oai":{"id":"oai:gifu-pu.repo.nii.ac.jp:00014596","sets":["212:261:309"]},"author_link":["35099","35101","35102","35105","35103","35100","35104"],"item_3_biblio_info_3":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-05","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"5","bibliographicPageEnd":"242","bibliographicPageStart":"239","bibliographicVolumeNumber":"76","bibliographic_titles":[{"bibliographic_title":"Die Pharmazie"},{"bibliographic_title":"Die Pharmazie","bibliographic_titleLang":"en"}]}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patients","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patients"},{"subitem_title":"Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patients","subitem_title_language":"en"}]},"item_type_id":"3","owner":"146","path":["309"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-01-01"},"publish_date":"2021-01-01","publish_status":"0","recid":"14596","relation_version_is_last":true,"title":["Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patients"],"weko_creator_id":"146","weko_shared_id":-1},"updated":"2023-06-19T07:41:26.853403+00:00"}